Company Profile



Vilnius, Lithuania

Founded Year




Operating Status


Social Media


Gediminas Peksys
Co-Founder, CEO

Jonas Bialopetravičius
Co-Founder, CTO

Darius Barušauskas
Co-Founder, Data Scientist

Naglis Ramanauskas
Co-Founder, Chief Medical Officer


Oxipit, a cutting-edge medical imaging company, is making waves in the healthcare industry with its innovative artificial intelligence (AI)-powered solutions. Leveraging the power of deep learning algorithms and advanced computer vision techniques, Oxipit is transforming the way medical imaging is conducted, significantly improving diagnostic accuracy and efficiency.

Oxipit's flagship product, ChestEye™, has emerged as a game-changer in the realm of radiology. This AI-powered solution is designed to aid radiologists in detecting and diagnosing chest abnormalities on chest X-rays.

By employing state-of-the-art deep learning algorithms, ChestEye™ enables rapid analysis and precise detection of various pathological conditions, including lung nodules, masses, fractures, and pneumothorax.

The underlying technology behind ChestEye™ is a result of years of research and development by Oxipit's team of dedicated experts. Their expertise in machine learning and medical imaging has culminated in a robust and reliable solution that seamlessly integrates into existing radiology workflows.

By automating the detection process, ChestEye™ reduces radiologists' workload, allowing them to focus on critical cases and making timely, accurate diagnoses.

In addition to ChestEye™, Oxipit has expanded its product portfolio with other groundbreaking solutions. Among them is SliceMap™, an AI-powered tool that revolutionizes the analysis of CT scans. By providing radiologists with a comprehensive visualization of CT slices in a 3D manner, SliceMap™ enables faster and more accurate detection of abnormalities, such as tumors, aneurysms, and vascular malformations.

This breakthrough technology allows for enhanced precision and efficiency in diagnosis, ultimately leading to better patient outcomes.

Oxipit's commitment to innovation doesn't end with its existing product line. The company continues to invest in research and development to tackle new challenges in medical imaging. With a dedicated team of experts and partnerships with leading medical institutions, Oxipit is at the forefront of AI-driven advancements in the field. Their relentless pursuit of excellence and desire to improve patient care is positioning Oxipit as a frontrunner in the global healthcare industry.

As the demand for AI-powered medical imaging solutions grows, Oxipit is rapidly expanding its presence in international markets. The company has successfully deployed its technologies in various healthcare facilities worldwide, gaining recognition and acclaim for their transformative impact on diagnostic processes.

Radiologists and healthcare professionals are embracing Oxipit's solutions for their ability to enhance accuracy, streamline workflows, and improve patient outcomes. The company's relentless pursuit of excellence, coupled with its commitment to improving patient care, positions Oxipit as a key player in the ongoing digital transformation of the healthcare industry.


ChestEye - AI for quality assurance in radiology

ChestEye Quality builds upon the vanguard capabilities of the ChestEye imaging suite, which supports 75 most common radiological findings covering 90% of pathologies encountered at a medical institution on a daily basis.

Similar Companies

About Us

futureTEKnow is a global database of emerging technology companies. Discover the latest disruptors and innovators in the field.



Trending Today